These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 28220655)

  • 1. PPARs in the central nervous system: roles in neurodegeneration and neuroinflammation.
    Zolezzi JM; Santos MJ; Bastías-Candia S; Pinto C; Godoy JA; Inestrosa NC
    Biol Rev Camb Philos Soc; 2017 Nov; 92(4):2046-2069. PubMed ID: 28220655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peroxisome proliferator-activated receptors (PPARs) as therapeutic target in neurodegenerative disorders.
    Agarwal S; Yadav A; Chaturvedi RK
    Biochem Biophys Res Commun; 2017 Feb; 483(4):1166-1177. PubMed ID: 27514452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PPARs in Neurodegenerative and Neuroinflammatory Pathways.
    Benedetti E; Cristiano L; Antonosante A; d'Angelo M; D'Angelo B; Selli S; Castelli V; Ippoliti R; Giordano A; Cimini A
    Curr Alzheimer Res; 2018 Feb; 15(4):336-344. PubMed ID: 28521669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biology and therapeutic applications of peroxisome proliferator- activated receptors.
    Menendez-Gutierrez MP; Roszer T; Ricote M
    Curr Top Med Chem; 2012; 12(6):548-84. PubMed ID: 22242855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elucidating the Neuroprotective Role of PPARs in Parkinson's Disease: A Neoteric and Prospective Target.
    Behl T; Madaan P; Sehgal A; Singh S; Sharma N; Bhatia S; Al-Harrasi A; Chigurupati S; Alrashdi I; Bungau SG
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peroxisome Proliferator-Activated Receptor Gamma Coactivator-1 Alpha as a Novel Target for Bipolar Disorder and Other Neuropsychiatric Disorders.
    Nierenberg AA; Ghaznavi SA; Sande Mathias I; Ellard KK; Janos JA; Sylvia LG
    Biol Psychiatry; 2018 May; 83(9):761-769. PubMed ID: 29502862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PPARs (Peroxisome Proliferator-activated Receptors) and Their Agonists in Alzheimer's Disease.
    Kumar M; Sharma AA; Datusalia AK; Khatik GL
    Med Chem; 2024; 20(8):781-798. PubMed ID: 38726789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PPAR agonists as therapeutics for CNS trauma and neurological diseases.
    Mandrekar-Colucci S; Sauerbeck A; Popovich PG; McTigue DM
    ASN Neuro; 2013 Dec; 5(5):e00129. PubMed ID: 24215544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PPARs in the brain.
    Heneka MT; Landreth GE
    Biochim Biophys Acta; 2007 Aug; 1771(8):1031-45. PubMed ID: 17569578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent Advances in Neuroinflammation Therapeutics: PPARs/LXR as Neuroinflammatory Modulators.
    Bastias-Candia S; Garrido A N; Zolezzi JM; Inestrosa NC
    Curr Pharm Des; 2016; 22(10):1312-23. PubMed ID: 26696410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pivotal Roles of Peroxisome Proliferator-Activated Receptors (PPARs) and Their Signal Cascade for Cellular and Whole-Body Energy Homeostasis.
    Lamichane S; Dahal Lamichane B; Kwon SM
    Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29565812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peroxisome proliferator-activated receptor (PPAR)β/δ, a possible nexus of PPARα- and PPARγ-dependent molecular pathways in neurodegenerative diseases: Review and novel hypotheses.
    Aleshin S; Strokin M; Sergeeva M; Reiser G
    Neurochem Int; 2013 Oct; 63(4):322-30. PubMed ID: 23811400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PPAR: a therapeutic target in Parkinson's disease.
    Chaturvedi RK; Beal MF
    J Neurochem; 2008 Jul; 106(2):506-18. PubMed ID: 18384649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Strategy of Targeting Peroxisome Proliferator-Activated Receptor (PPAR) in the Treatment of Neuropsychiatric Disorders.
    Matrisciano F; Pinna G
    Adv Exp Med Biol; 2023; 1411():513-535. PubMed ID: 36949324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of peroxisome proliferator-activated receptors (PPARs) and retinoic acid receptors (RXRs) in rat cortical neurons.
    Cimini A; Benedetti E; Cristiano L; Sebastiani P; D'Amico MA; D'Angelo B; Di Loreto S
    Neuroscience; 2005; 130(2):325-37. PubMed ID: 15664689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PPARs as Nuclear Receptors for Nutrient and Energy Metabolism.
    Hong F; Pan S; Guo Y; Xu P; Zhai Y
    Molecules; 2019 Jul; 24(14):. PubMed ID: 31336903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent Insights on the Role of PPAR-β/δ in Neuroinflammation and Neurodegeneration, and Its Potential Target for Therapy.
    Strosznajder AK; Wójtowicz S; Jeżyna MJ; Sun GY; Strosznajder JB
    Neuromolecular Med; 2021 Mar; 23(1):86-98. PubMed ID: 33210212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Present concepts and future outlook: function of peroxisome proliferator-activated receptors (PPARs) for pathogenesis, progression, and therapy of cancer.
    Sertznig P; Seifert M; Tilgen W; Reichrath J
    J Cell Physiol; 2007 Jul; 212(1):1-12. PubMed ID: 17443682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PPARs at the crossroads of lipid signaling and inflammation.
    Wahli W; Michalik L
    Trends Endocrinol Metab; 2012 Jul; 23(7):351-63. PubMed ID: 22704720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear receptors in neurodegenerative diseases.
    Skerrett R; Malm T; Landreth G
    Neurobiol Dis; 2014 Dec; 72 Pt A():104-16. PubMed ID: 24874548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.